These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29113274)

  • 1. Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
    Buranrat B; Suwannaloet W; Naowaboot J
    Oncol Lett; 2017 Nov; 14(5):6243-6250. PubMed ID: 29113274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative and antimigratory activities of bisphosphonates in human breast cancer cell line MCF-7.
    Buranrat B; Bootha S
    Oncol Lett; 2019 Aug; 18(2):1246-1258. PubMed ID: 31423185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin induces caspase-dependent apoptosis and activates P53 in OCM-1 cells.
    Wang Y; Xu SL; Wu YZ; Zhao MS; Xu WJ; Yang HY; Li YX
    Exp Eye Res; 2013 Aug; 113():128-34. PubMed ID: 23727160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Ca
    Abdoul-Azize S; Buquet C; Li H; Picquenot JM; Vannier JP
    Oncogene; 2018 Sep; 37(36):4979-4993. PubMed ID: 29795329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death.
    Buranrat B; Connor JR
    Oncol Rep; 2015 Nov; 34(5):2790-6. PubMed ID: 26352101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells.
    Dewidar SA; Hamdy O; Soliman MM; El Gayar AM; El-Mesery M
    Med Oncol; 2023 Dec; 41(1):7. PubMed ID: 38051378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
    De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
    Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.
    Shen YY; Yuan Y; Du YY; Pan YY
    Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and antimigratory effects of
    Buranrat B; Mairuae N; Kanchanarach W
    Biomed Rep; 2017 Apr; 6(4):441-448. PubMed ID: 28413643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
    Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.
    Shen Y; Du Y; Zhang Y; Pan Y
    Mol Med Rep; 2015 Jul; 12(1):456-62. PubMed ID: 25738757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
    Kotamraju S; Williams CL; Kalyanaraman B
    Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Farghadani R; Seifaddinipour M; Rajarajeswaran J; Abdulla MA; Mohd Hashim NB; Khaing SL; Salehen NB
    PeerJ; 2019; 7():e7686. PubMed ID: 31608167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
    Chewchuk S; Guo B; Parissenti AM
    PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Baneh (
    Pasban-Aliabadi H; Sobhani V; Esmaeili-Mahani S; Najafipour H; Askari A; Jalalian H
    Iran J Pharm Res; 2019; 18(4):1959-1966. PubMed ID: 32184861
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
    Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.
    Tavangar F; Sepehri H; Saghaeian Jazi M; Asadi J
    J Chem Biol; 2017 Jul; 10(3):143-150. PubMed ID: 28685000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Keyvanloo Shahrestanaki M; Bagheri M; Ghanadian M; Aghaei M; Jafari SM
    J Cell Biochem; 2019 Oct; 120(10):18309-18319. PubMed ID: 31161672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
    Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Szczęśniak-Sięga B; Wesołowska O
    Anticancer Res; 2019 Feb; 39(2):727-734. PubMed ID: 30711951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.